Guillain Barre Syndrome
Keywords:
Guillain-Barre syndrome/diagnosis/mortality, Electromyography.Abstract
Introduction: Guillain Barre Syndrome is a demyelinating, acute, inflammatory polyneuropathy mediated by immune mechanisms, with much variable results and clinical development, and constitutes the most frequent cause of acute flaccid paralysis generalized in the world.Objective: to clinically and epidemiologically characterize Gullain Barre patients, and also the electromyographic variants, the application of diagnosis criteria, and further evolution.
Material and method: a descriptive retrospective research was carried out from January 2009 to September 2013. The sample consisted of 12 patients admitted with diagnosis of Guillain Barré.
Results: most of the cases presented in 2009, with a predominance of female patients of ages 50-59 years. The most frequent predisposing factors are the respiratory tracts infections, and the variant of acute demyelinating inflammatory polyneuropathy. Diagnosis criteria were applied on more than 90% of the cases. Most patients were admitted alive with sequels.
Conclusions: the 50% of the patients were included within the age groups 50-59 years, the female sex predominating, as well as the antecedent of respiratory tracts infections, the variant of acute demyelinating inflammatory polyneuropathy was the most frequent, diagnosis criteria were applied in most of the patients, and there was only one death.
Downloads
References
1. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. [Internet] 2011 [Citado 17 de octubre de 2013]; 36(2): [Aprox. 10p.]. Disponible en : http://www.ncbi.nlm.nih.gov/pubmed/21422765
2. Anand B. Pithadia K, Nimisha K. Review on Guillain-Barré syndrome. Pharmacological. [Internet] 2010 [Citado 17 de octubre de 2013]; 62: [Aprox. 12p.]. Disponible en: http://www.if-pan.krakow.pl/pjp/pdf/2010/2_220.pdf
3. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009–2010. Am J Epidemiol. [Internet] 2012 [Citado 17 de octubre de 2013]; 175(11): [Aprox. 9p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22582210
4. Sejvar JJ, Pfeifer D, Schonberger LB. Guillain-Barré syndrome following influenza vaccination: causal or coincidental? Curr Infect Dis Rep. [Internet] 2011 [Citado 17 de octubre de 2013]; 13(4): [Aprox. 11p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21681501
5. Galeotti F, Massari M, D´Alessandro R, Begui E, Chio A, et al. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. Eur J Epidemiol. [Internet] 2013 [Citado 17 de octubre de 2013]; 28(5): [Aprox. 11p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23543123
6. Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. [Internet] 2012 [Citado 17 de octubre de 2013]; 7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22786475
7. Kuitwaard K, de Gelder J, Tio-Gillen AP, et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol. [Internet] 2009 [Citado 17 de octubre de 2013]; 66(5): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19938102
8. Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsvel R, et al. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. [Internet] 2010 Jun [Citado 17 de octubre de 2013]; 67(6): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20517939
9. Roodbol J, de Wit MCY, Walgaard C, de Hoog M, Catsman- Berrevoets CE, et al. Recognizing Guillain- Barré syndrome in preschool children. Neurology. [Internet] 2011 [Citado 17 de octubre de 2013]; 76(9): [Aprox. 3p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21357832
10. Taboada R, González G, García A, Alberti M, Scavone C. Protocolo diagnóstico y terapéutico del Síndrome de Guillain-Barré. Archivos de Pediatría del Uruguay. [Internet] 2008 [Citado 17 de octubre de 2013]; 79 (1): [Aprox. 5p.]. Disponible en: http://www.sup.org.uy/Archivos/adp79-1/pdf/adp79-1_8.pdf
11. Parellada J, Hidalgo AO. Comportamiento de los pacientes con Síndrome de Guillain-Barré grave. Estudio cooperativo en dos Hospitales Clínico- Quirúrgicos. Rev Cub Med Int Emerg. [Internet] 2002 [Citado 17 de octubre de 2013]; 1(1): [Aprox. 2p.]. Disponible en: http://bvs.sld.cu/revistas/mie/vol1_1_02/mie12102.htm
12. Lestayo Z, Hernández JL. Análisis del comportamiento del síndrome de Guillain-Barré. Consensos y discrepancias. Rev Neurol. [Internet] 2008 [Citado 17 de octubre de 2013]; 46 (4): [Aprox. 7p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18327746?dopt=Abstract
13. Wise ME, Viray M, Sejvar JJ. Guillain-Barré syndrome during the 2009–2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol. [Internet] 2012 [Citado 17 de octubre de 2013]; 175(11): [Aprox. 9p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22582209
14. Tokars JI, Lewis P, DeStefano F, et al. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009–2010 seasonal influenza vaccines: results from self-controlled analyses. Pharmacoepidemiol Drug Saf. [Internet] 2012 [Citado 17 de octubre de 2013]; 21(5): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22407672
15. De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, et al. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec. JAMA. [Internet] 2012 [Citado 17 de octubre de 2013]; 308(2): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22782419
16. Kumar B, Agrawal N, Patra S, Manjunath CN. Occurrence of Guillain-Barré syndrome as an immune mediated complication after thrombolysis with streptokinase for acute anterior wall myocardial infarction: a caution to be vigilant. BMJ Case Reports. [Internet] 2013 [Citado 17 de octubre de 2013]; 2013. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24099761
17. Melano E, Carrillo E, Gulías A, Ávila JA. Síndrome de Guillain-Barré en el anciano: un estudio retrospectivo. Arch Neurocien. [Internet] 2004 [Citado 17 de octubre de 2013]; 9(2): [Aprox. 3p.]. Disponible en: http://www.scielo.org.mx/scielo.php?pid=S0187-
18. Tokars JI, Lewis P, DeStefano F, et al. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009–2010 seasonal influenza vaccines: results from self-controlled analyses. Pharmacoepidemiol Drug Saf. [Internet] 2012 [Citado 20 de mayo de 2013]; 21(5): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22407672
19. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. [Internet] 2011 [Citado 17 de octubre de 2013]; 29(3): [Aprox. 13p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20600491
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
